• Mashup Score: 0

    In the past years cancer treatments have drastically changed, mainly due to the development of immune checkpoint inhibitors capable of immune modulation in vivo, thus providing major clinical benefit in a number of malignancies. Simultaneously, considerable technical refinements have opened new prospects for the development of immune cell-based medicinal products and unprecedented success with…

    Tweet Tweets with this article
    • Our #TranslationalMedicine link of the week chosen by @SWOG's @recnac1 & Jimmy Rae, PhD: Clinical Trials of Cellular Therapies in Solid Tumors https://t.co/IXcUY2igIf https://t.co/RRX4KKoUM2

  • Mashup Score: 0

    The field of anesthesia has always been at the forefront of innovation and technology, and the integration of Artificial Intelligence (AI) represents the next frontier in anesthesia care. The use of AI and its subtypes, such as machine learning, has the potential to improve efficiency, reduce costs, and ameliorate patient outcomes. AI can assist with decision making, but its primary advantage…

    Tweet Tweets with this article
    • Exploring Artificial Intelligence in Anesthesia: A Primer on Ethics, and Clinical Applications #some4surgery #some4AI #AI https://t.co/qFc4qV9uZz

  • Mashup Score: 0

    Tailored treatment with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has revolutionized the outcome of acute promyelocytic leukemia (APL) from a uniformly fatal disease to one of the most curable malignant diseases in humans. Due to its high efficacy, ATO/ATRA is the standard first-line therapy in younger adult, non-high-risk APL patients. However, early death is still a major issue…

    Tweet Tweets with this article
    • Management of Acute Promyelocytic Leukemia at Extremes of Age https://t.co/pWDVyvb64e #mdpicancers #leusm via @Cancers_MDPI

  • Mashup Score: 0

    We performed a retrospective single-center analysis to investigate the diagnostic yield of bone marrow puncture in patients with liver cirrhosis and cytopenia. Liver cirrhosis patients receiving bone marrow aspiration or biopsy for the diagnostic work-up of otherwise unexplained peripheral blood cytopenia at our institution between 2004 and 2020 were enrolled in this study. We evaluated findings…

    Tweet Tweets with this article
    • Confirmation that bone marrow analysis is not usually required in patients with cytopenias and advanced liver disease. Only 1/118 patients was found to have myelodysplasia to explain the cytopenia. https://t.co/yiW0pvM3RR https://t.co/TWT4gjk3sa

  • Mashup Score: 3

    Frontline acute myeloid leukemia (AML) treatment is determined by a combination of patient and genetic factors. This includes patient fitness (i.e., comorbidities that increase the risk of treatment-related mortality) and genetic characteristics, including cytogenetic events and gene mutations. In older unfit patients, the standard of care treatment is typically venetoclax (VEN) combined with…

    Tweet Tweets with this article
    • Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia https://t.co/2St6dUzbU9 #mdpicancers via @Cancers_MDPI #AML #leusm https://t.co/zGinkdeWQR

  • Mashup Score: 1

    The Western diet is a modern dietary pattern characterized by high intakes of pre-packaged foods, refined grains, red meat, processed meat, high-sugar drinks, candy, sweets, fried foods, conventionally raised animal products, high-fat dairy products, and high-fructose products. The present review aims to describe the effect of the Western pattern diet on the metabolism, inflammation, and…

    Tweet Tweets with this article
    • Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review https://t.co/TgaIC4EiqQ